These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 19664602)
21. Effect of receptor phosphorylation on the binding between IRS-1 and IGF-1R as revealed by surface plasmon resonance biosensor. Huang M; Lai WP; Wong MS; Yang M FEBS Lett; 2001 Sep; 505(1):31-6. PubMed ID: 11557037 [TBL] [Abstract][Full Text] [Related]
22. Insulin receptor structure and its implications for the IGF-1 receptor. Lawrence MC; McKern NM; Ward CW Curr Opin Struct Biol; 2007 Dec; 17(6):699-705. PubMed ID: 17851071 [TBL] [Abstract][Full Text] [Related]
23. Spatial arrangement of LD motif-interacting residues on focal adhesion targeting domain of Focal Adhesion Kinase determine domain-motif interaction affinity and specificity. Gupta AB; Mukherjee S; Pan CQ; Velazquez-Campoy A; Sivaraman J; Low BC Biochim Biophys Acta Gen Subj; 2020 Jan; 1864(1):129450. PubMed ID: 31676296 [TBL] [Abstract][Full Text] [Related]
24. Development of focal adhesion kinase inhibitors in cancer therapy. Ma WW Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276 [TBL] [Abstract][Full Text] [Related]
25. TRAF2 Cooperates with Focal Adhesion Signaling to Regulate Cancer Cell Susceptibility to Anoikis. da Silva SD; Xu B; Maschietto M; Marchi FA; Alkailani MI; Bijian K; Xiao D; Alaoui-Jamali MA Mol Cancer Ther; 2019 Jan; 18(1):139-146. PubMed ID: 30373932 [TBL] [Abstract][Full Text] [Related]
26. Porcine IGF-1R synonymous mutations in the intracellular domain affect cell proliferation and alter kinase activity. Wang C; Liu S; Wu Q; Cheng Y; Feng T; Song J; Yang R; Geng H; Lu G; Wang S; Hao L Int J Biol Macromol; 2020 Jun; 152():147-153. PubMed ID: 32109480 [TBL] [Abstract][Full Text] [Related]
27. Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells. Zovko A; Novak M; Hååg P; Kovalerchick D; Holmlund T; Färnegårdh K; Ilan M; Carmeli S; Lewensohn R; Viktorsson K Oncotarget; 2016 Aug; 7(31):50258-50276. PubMed ID: 27384680 [TBL] [Abstract][Full Text] [Related]
28. Syndecan-2 cytoplasmic domain up-regulates matrix metalloproteinase-7 expression via the protein kinase Cγ-mediated FAK/ERK signaling pathway in colon cancer. Jang B; Jung H; Choi S; Lee YH; Lee ST; Oh ES J Biol Chem; 2017 Sep; 292(39):16321-16332. PubMed ID: 28821612 [TBL] [Abstract][Full Text] [Related]
29. An investigation of the ligand binding properties and negative cooperativity of soluble insulin-like growth factor receptors. Surinya KH; Forbes BE; Occhiodoro F; Booker GW; Francis GL; Siddle K; Wallace JC; Cosgrove LJ J Biol Chem; 2008 Feb; 283(9):5355-63. PubMed ID: 18056713 [TBL] [Abstract][Full Text] [Related]
30. Direct interaction of the N-terminal domain of focal adhesion kinase with the N-terminal transactivation domain of p53. Golubovskaya VM; Finch R; Cance WG J Biol Chem; 2005 Jul; 280(26):25008-21. PubMed ID: 15855171 [TBL] [Abstract][Full Text] [Related]
31. Structure-Based Virtual Screening, Synthesis and Biological Evaluation of Potential FAK-FAT Domain Inhibitors for Treatment of Metastatic Cancer. Kandil SB; Jones SR; Smith S; Hiscox SE; Westwell AD Molecules; 2020 Jul; 25(15):. PubMed ID: 32751931 [TBL] [Abstract][Full Text] [Related]
32. Visualization of Ligand-Bound Ectodomain Assembly in the Full-Length Human IGF-1 Receptor by Cryo-EM Single-Particle Analysis. Zhang X; Yu D; Sun J; Wu Y; Gong J; Li X; Liu L; Liu S; Liu J; Wu Y; Li D; Ma Y; Han X; Zhu Y; Wu Z; Wang Y; Ouyang Q; Wang T Structure; 2020 May; 28(5):555-561.e4. PubMed ID: 32275863 [TBL] [Abstract][Full Text] [Related]
33. PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule. Su X; Cheng K; Liu Y; Hu X; Meng S; Cheng Z Amino Acids; 2015 Jul; 47(7):1409-19. PubMed ID: 25854877 [TBL] [Abstract][Full Text] [Related]
34. The effect of forced expression of mutated K-RAS gene on gastrointestinal cancer cell lines and the IGF-1R targeting therapy. Matsunaga Y; Adachi Y; Sasaki Y; Koide H; Motoya M; Nosho K; Takagi H; Yamamoto H; Sasaki S; Arimura Y; Tokino T; Carbone DP; Imai K; Shinomura Y Mol Carcinog; 2017 Feb; 56(2):515-526. PubMed ID: 27312358 [TBL] [Abstract][Full Text] [Related]
35. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Min HY; Yun HJ; Lee JS; Lee HJ; Cho J; Jang HJ; Park SH; Liu D; Oh SH; Lee JJ; Wistuba II; Lee HY Mol Cancer; 2015 Jun; 14():113. PubMed ID: 26041671 [TBL] [Abstract][Full Text] [Related]
36. Model for the complex between the insulin-like growth factor I and its receptor: towards designing antagonists for the IGF-1 receptor. Epa VC; Ward CW Protein Eng Des Sel; 2006 Aug; 19(8):377-84. PubMed ID: 16772308 [TBL] [Abstract][Full Text] [Related]
37. Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition. Croasdale R; Wartha K; Schanzer JM; Kuenkele KP; Ries C; Mayer K; Gassner C; Wagner M; Dimoudis N; Herter S; Jaeger C; Ferrara C; Hoffmann E; Kling L; Lau W; Staack RF; Heinrich J; Scheuer W; Stracke J; Gerdes C; Brinkmann U; Umana P; Klein C Arch Biochem Biophys; 2012 Oct; 526(2):206-18. PubMed ID: 22464987 [TBL] [Abstract][Full Text] [Related]
38. c-Src, Insulin-Like Growth Factor I Receptor, G-Protein-Coupled Receptor Kinases and Focal Adhesion Kinase are Enriched Into Prostate Cancer Cell Exosomes. DeRita RM; Zerlanko B; Singh A; Lu H; Iozzo RV; Benovic JL; Languino LR J Cell Biochem; 2017 Jan; 118(1):66-73. PubMed ID: 27232975 [TBL] [Abstract][Full Text] [Related]
39. XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer. Schanzer JM; Wartha K; Moessner E; Hosse RJ; Moser S; Croasdale R; Trochanowska H; Shao C; Wang P; Shi L; Weinzierl T; Rieder N; Bacac M; Ries CH; Kettenberger H; Schlothauer T; Friess T; Umana P; Klein C MAbs; 2016; 8(4):811-27. PubMed ID: 26984378 [TBL] [Abstract][Full Text] [Related]
40. Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury. Niu XL; Li J; Hakim ZS; Rojas M; Runge MS; Madamanchi NR J Biol Chem; 2007 Jul; 282(27):19808-19. PubMed ID: 17500057 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]